This study is testing Glycyrrhizin (GLY) in men with prostate cancer who are planning to have surgery. You would either receive 75 mg of Glycyrrhizin daily, 150 mg of Glycyrrhizin daily, or no Glycyrrhizin, for about 5 weeks before your surgery. Researchers want to see if Glycyrrhizin can reduce prostate-specific antigen (PSA) levels, which is a marker for prostate cancer, before surgery. To join, you must be at least 18 years old, have prostate cancer that hasn't been treated yet, and be scheduled for a radical prostatectomy (surgery to remove the prostate). This study is looking for 60 participants, but its current recruitment status is unclear.

Study design

This is a pilot, randomized study where participants are assigned by chance to one of three groups. It is an interventional study, meaning participants will receive a specific treatment or observation.

What's involved

You would take Glycyrrhizin daily for about 5 weeks before your prostatectomy surgery. Your PSA levels will be checked after this treatment period.

Compensation

Not stated in the trial record.

Follow-up

The main goal is to check changes in PSA levels after treatment and before surgery, which is measured at 2 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.